ClinicalTrials.Veeva

Menu

The Acute Coronary Syndrome Study (ACS)

U

Ullevaal University Hospital

Status

Unknown

Conditions

Acute Coronary Syndrome

Treatments

Other: Care as usual. No intervention. (Control group)
Other: Early discharge

Study type

Interventional

Funder types

Other

Identifiers

NCT01027026
REK: 6.2008.1724

Details and patient eligibility

About

The investigators will make a prospective study in which they will look at the economics and security of the treatment of patients with acute coronary syndrome.

The investigators want to do a randomized trial. One group will be treated as they have been treated at Ullevål University Hospital (UUS) in recent years, and the other group will be returned to their refering hospital the same day. The objective of this study will be to provide increased knowledge about whether the rapid discharge from the intervention center is associated with differences in costs or security.

Full description

The topic of this study is whether patients with Acute coronary syndrome (ACS)may can be transferred to their refering hospital same day that they arrived intervention hospital.

This is to see if one can reduce the hospital stay and costs for the intervention center, and the total hospitalization time.

and this rapid transport not give more medical complications

Our 1 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day, will reduce the length of stay in intervention center without an increase for the stay at the refering hospital.

Our 2 hypothesis is that patients with ACS, who are transported back to the refering hospital the same day as the treatment is performed, have no more complications than those who stay overnight in the intervention hospital.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with acute coronary syndrome who are referred from other hospitals

Exclusion criteria

  • Patients younger than 18years.
  • Known mental retardation, dementia or harmful use of alcohol or drugs.
  • Allergy or intolerance to ASA and / or clopidogrel.
  • Patients who have previously been involved in this study.
  • Acute STEMI infarction for less than 72 hours ago.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 2 patient groups

Group 1 Fast Track Group
Experimental group
Description:
The patients are discharged the same day after coronary angiography to the refering Hospital
Treatment:
Other: Early discharge
Group 2: Ordinary care
Active Comparator group
Description:
Ordinary Cardiology care in the Intervention hospital
Treatment:
Other: Care as usual. No intervention. (Control group)

Trial contacts and locations

1

Loading...

Central trial contact

Odd Johansen, ph.d MD; Jack Gunnar Andersen, Master of Management

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems